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Abstract
Background: Primary central nervous system lymphoma (PCNSL) is a rare, aggressive brain neoplasm that accounts
for roughly 2-6% of primary brain tumors. In contrast, glioblastoma (GBM) is the most frequent and severe glioma
subtype, accounting for approximately 50% of diffuse gliomas. The aim of the present study was to evaluate
morphological MRI characteristics in histologically-proven PCNSL and GBM at the time of their initial presentation.
Methods: We retrospectively evaluated standard diagnostic MRI examinations in 54 immunocompetent patients
(26 female, 28 male; age 62.6 ± 11.5 years) with histologically-proven PCNSL and 54 GBM subjects (21 female, 33
male; age 59 ± 14 years).
Results: Several significant differences between both infiltrative brain tumors were found. PCNSL lesions enhanced
homogenously in 64.8% of cases, while nonhomogeneous enhancement was observed in 98.1% of GBM cases.
Necrosis was present in 88.9% of GBM lesions and only 5.6% of PCNSL lesions. PCNSL presented as multiple lesions
in 51.9% cases and in 35.2% of GBM cases; however, diffuse infiltrative type of brain involvement was observed only
in PCNSL (24.1%). Optic pathways were infiltrated more commonly in PCNSL than in GBM (42.6% vs. 5.6%,
respectively, p <0.001). Other cranial nerves were affected in 5.6% of PCNSL, and in none of GBM. Signs of bleeding
were rare in PCNSL (5.6%) and common in GBM (44.4%); p < 0.001. Both supratentorial and infratentorial localization
was present only in PCNSL (27.7%). Involvement of the basal ganglia was more common in PCNSL (55.6%) than in
GBM (18.5%); (p < 0.001). Cerebral cortex was affected significantly more often in GBM (83.3%) than in PCNSL (51.
9%); mostly by both enhancing and non-enhancing infiltration.
Conclusion: Routine morphological MRI is capable of differentiating between GBM and PCNSL lesions in many
cases at time of initial presentation. A solitary infiltrative supratentorial lesion with nonhomogeneous enhancement
and necrosis was typical for GBM. PCNSL presented with multiple lesions that enhanced homogenously or as
diffuse infiltrative type of brain involvement, often with basal ganglia and optic pathways affection.
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Background
Although glioblastoma (GBM) and primary central ner-
vous lymphoma (PCNSL) differ in many respects, it is
often reported that morphological differentiation between
them by MRI is difficult [1]. PCNSL is a rare, aggressive
brain neoplasm that may involve the brain, leptomeninges,
spinal cord and eyes without systematic lymphomatous
involvement, and accounts for approximately 2-6% of
primary brain tumors [2]. PCNSL is typically diffuse large
B-cell lymphoma (DLBCL), and rarely other types such as
Burkitt lymphoma, T cell lymphoma or Hodgkin
lymphoma [3, 4]. In immunocompetent patients, PCNSL
usually affects older individuals with a slight male predi-
lection and its incidence has been increasing in recent
years [5–8]. Immunocompromised patients especially with
AIDS have an increased risk of PCNSL, which develops at
younger age [5]. The treatment of choice for PCNSL is ra-
diation therapy and/or chemotherapy [9]. In contrast, gli-
omas are the most common primary brain tumors,
accounting for roughly 70% of all primary brain tumors in
adults. GBM is the most frequent and severe glioma sub-
type and accounts for about approximately 50% of diffuse
gliomas. It is characterized by infiltration beyond the en-
hancing margin and with rapid growth [10, 11]. The pri-
mary treatment for GBM is surgical resection followed by
radiation therapy and chemotherapy [12].
It has been suggested that MRI has limited potential in
differentiating between PCNSL and GBM [1], and several
studies have employed advanced MRI techniques such as
diffusion-weighed imaging (DWI), MR spectroscopy or
dynamic contrast enhancement [13–16]. Systematic evalu-
ation of conventional morphological MRI manifestations
of both tumors is, however, lacking. Therefore, we
endeavored to compare morphological signs on MRI in
sufficiently large groups of GBM and PCNSL patients at
their initial presentation, thus on the first diagnostic MRI.
Only immunocompetent PCNSL subjects were included
due to potential confounding effects of pharmacotherapy




We retrospectively evaluated all available MRI examina-
tions and medical records in patients with histologically
proven PCNSL and GBM. All patients provided written,
informed consent to treatment and agreed with publishing
medical data in scientific literature in anonymous form.
This retrospective study was approved by the Ethics com-
mittee of Na Homolce Hospital, Prague, Czech Republic.
Group A (PCNSL) Patients with histologically-proven
CNS lymphoma acquired at our institution from 2007–
2015 were included. DLBCL was histologically proven in
all patients, and systemic lymphoma was excluded by
bone marrow biopsy, whole-body computed tomography
(CT) or whole-body positron emission tomography/CT.
From 64 subjects with PCNSL, 54 were immunocompe-
tent while 10 were excluded due to known immunodefi-
ciency. Thus, 54 immunocompetent PCNSL patients
were included. Histological specimens were obtained by
stereotactic biopsy (N = 43), open surgical biopsy (N = 6)
or by open surgical resection (N = 5).
Group B (GBM) Fifty-four consecutive patients with
histologically proven GBM (WHO grade IV) acquired at
our institution from 2012-2013 were additionally in-
cluded. Subjects with secondary upgrade of previously
known low grade glioma were excluded. The diagnosis
was confirmed by histological examination of specimens
obtained by open surgery with one exception, in which
the specimen was obtained by stereotactic biopsy.
MRI examination
All MRI examinations were performed at different
whole-body 1.5 T scanners and included the following
sequences: fast spin echo (FSE) T2-weighted images (T2
WI), T2-weighted fluid-attenuated inversion recovery
(FLAIR), susceptibility-weighted images (SWI) or T2*
gradient echo (GE). Inconstantly diffusion-weighted im-
ages (DWI; b-value 1000) and ADC maps were available
(in 35 PCNSL patients and in 51 GBM patients). After
intravenous gadolinium contrast administration, spin
echo (SE) T1 WI or GE T1 3D were always performed.
All MRI examinations were evaluated by consensual
reading by 2 experienced radiologists.
The following signs were assessed on the initial MRI
examination (for details, see Table 3): lesion localization;
quantity (solitary, multiple and diffuse infiltrative) and
quality (demarcated, infiltrative and diffuse infiltrative)
of the lesions; type of enhancement and necrosis
presence; diffusion restriction presence; meningeal and/
or ependymal involvement; cranial nerve involvement;
involvement of the corpus callosum, butterfly pattern;
involvement of the basal ganglia; presence of perifocal
vasogenic edema; signs of bleeding. Inclusion criteria for
solitary or multiple infiltrative lesions were as follows (at
least one criterion): ill-defined borders; non-enhancing
portions of tumor beyond enhancing portion; infiltration
of the ependyma, meninges or cranial nerves. Diffuse
infiltrative lesions were defined as follows: involvement
of both white and grey matter by enhancing tumorous
affection (which was nonhomogenous, patchy, worm-
like, stripy, etc.) and non-enhancing tumorous infiltra-
tion, which was spread along to large white matter tracts
and continuously affected at least a) more than 2/3 of
one cerebral hemisphere and/or b) different extend of
both supratentorial and infratentorial regions. See also
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Fig. 1. Inclusion criteria for meningeal and ependymal
involvement were thickening and enhancing meningeal
/ependymal surfaces, which can be smooth, irregular or
nodular.
Statistics
Data were expressed as mean ± SD and as median.
Categorical values were analyzed using the chi-squared
test. Unpaired t-test was used for the comparison of the
time intervals. P-values <0.05 were considered signifi-
cant. Analyses were performed using STATISTICA soft-
ware version 12.
Results
Patient and clinical data
Patient demographic data are summarized in Table 1. In
the Table 1 you can also find detailed data about the
time intervals from clinical onset to initial brain MRI
and initial MRI to intervention (open surgery or stereo-
tactic biopsy). The time interval between clinical onset
and initial brain MRI did not significantly differ between
PCNSL and GBM; however interval between the initial
MRI and stereotactic biopsy/surgery was significantly
longer in PCNSL subjects (mean 59 ± 118 days, median
30 days) in comparison to GBM patients (mean 9 ±
7 days, median 8 days), (p = 0.002).
The patients presented with various clinical manifesta-
tions (in some patients a combination of multiple mani-
festations were present; see Table 2). The most common
manifestations included organic brain syndrome, signs
Fig. 1 PCNSL. Diffuse infiltrative brain affection
Table 1 Patient selection data
PCNSL GBM





Age 62.6 ± 11.5 years
(median 65 years)
59 ± 14 years
(median 62 years)
Interval from the first clinical
manifestation to the first MRI








Interval from the first MRI to
stereobiopsy or surgery








Max maximum, min minimum, NO number
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of intracranial hypertension, paresis, vertigo or phatic
disorder. PCNSL patients presented significantly more
often with cranial nerve dysfunction and visual disturb-
ance then GBM subjects, (p = 0.012) and also in organic
brain syndrome, (p = 0.038). GBM patients presented
significantly more often by seizures then PCNSL pa-
tients, (p = 0.008).
MRI findings
Initial diagnostic MRI results for both groups are sum-
marized in Table 3. PCNSL lesions were generally local-
ized supratentorially (66.7%). PCNSL affected both white
and grey matter, basal ganglia involvement was present
in 55.6%, and cortical grey matter was affected in 51.9%.
Cortical grey matter was involved by both enhancing
and non-enhancing tumorous infiltration in 37.1% of
cases, only enhancing portion was present in 3.7% of
cases, only non-enhancing infiltration was seen in 11.1%
of cases. Solitary affection of white matter was found
only in 7.4%; in 3.8% an isolated involvement of basal
ganglia was present and in one case (1.9%) solitary





Organic brain syndrome 22 12
Signs of intracranial hypertension 16 23
Paresis 16 19
Vertigo 12 13
Phatic disorder 11 14
Visual disturbances 7 3
Cranial nerve dysfunction
other than visual disturbance
5 0
Fatigue 4 7
Dysesthesia or hypesthesia 4 1
Seizure 1 9
NO number
Table 3 MRI findings in PCNSL and GBM at the time of initial evaluation
MRI finding PCNSL GBM p-value
Localization only supratentorial 66.7% 98.1% <0.001
only infratentorial 5.5% 1.9% 0.308
supra- and infratentorial 27.7% 0% <0.001
Type of lesions solitary demarcated lesion 3.7% 13% 0.046
solitary infiltrative type 20.4% 51.9% 0.121
multiple infiltrative lesions 51.9% 35.2% 0.081
diffuse infiltrative type 24.1% 0% <0.001
Type of enhancement homogeneous 64.8% 0% <0.001
nonhomogeneous 14.8% 98.1% <0.001
diffuse infiltrative – worm-like, patchy, stripy… 20.4% 0% <0.001
presence of necrosis 5.6% 88.9% <0.001
Involvement of brain surface without reaching brain surface 12.9% 11.1% 0.567
reaching brain surface 87% 88.9% 0.846
meningeal infiltration 35.2% 46.3% 0.240
ependymal infiltration 53.7% 37% 0.054
Optic nerves, chiasma or tracts involvement 42.6% 5.6% <0.001
Cranial nerves involvement (optical nerves and tracts excluded) 5.6% 0% 0.079
Corpus callosum infiltration 42.6% 44.4% 0.846
Butterfly pattern 24.1% 14.8% 0.224
Basal ganglia involvement 55.6% 18.5% <0.001
Cerebral cortex involvement 83.3% 51.9% <0.001
aDWI free diffusion 1.9% 10.4% 0.189
restricted diffusion in some part of the solid 97% 89.6% 0.189
Signs of bleeding 5.6% 44.4% <0.001
Presence of vasogenic edema 92.6% 83.3% 0.139
aDWI was available in 35 PCNSL patients and 51 GBM patients. Statisticaly significant results are in bold (p less than 0.05)
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infiltration of hypothalamus or vestibular nerve was
found. At time of initial MRI, PCNSL appeared as mul-
tiple infiltrative lesions in 51.9% of cases, as a solitary infil-
trative lesion in 20.4% of cases and as a diffuse infiltrative
affection in 24.1% (Fig. 1). Solitary demarcated lesions
were rare (3.7%). PCNSL enhanced homogenously
(64.8%), vasogenic perifocal edema was present in most
cases (92.6%), and diffusion restriction was detected in
97% of cases (Fig. 2). Optic nerves and tracts were infil-
trated in 42.6% of cases (Fig. 3). Other cranial nerves were
affected in 5.6% of PCNSL cases; in one case (1.9%) the
optic and trigeminal nerve was affected, and in one case
(1.9%) the optic nerves and both auditory and facial nerves
were involved and in one case (1.9%) solitary infiltration
of the auditory nerve was present without other brain le-
sions (Fig. 4a, b). PCNSL typically reached the surface of
the brain (87%) with meningeal infiltration present in
35.2% of cases and ependymal infiltration in 53.7% of
cases. Signs of bleeding (5.6%) were rare.
Nearly all lesions in GBM subjects were localized
supratentorially (98.1%); solitary infiltrative lesions were
present in 51.9% of cases and multiple lesions in 35.2%.
Nonhomogeneous enhancement of GBM lesions was de-
tected in 98.1% of cases and necrosis was present in
88.9% of cases (Fig. 5). GBM dominantly affected white
matter; however, in most cases also cortical grey matter
was affected (83.3%). In case of cortical involvement by
GBM (83.3%), in 63% of cases cortex was affected by en-
hancing and also non-enhancing portion of tumorous
infiltration; in 20.3% of cases cortex was affected only by
non-enhancing portion of tumor. Basal ganglia were
target in 18.5% and mostly in their margins. Isolated in-
volvement of cortical grey matter was not found. GBM
very often reached the surface of the brain (88.9%), and
meningeal infiltration was found in 46.3% of cases and
ependymal infiltration in 37% of cases (Fig. 6). Vasogenic
edema was present in 83.3% of cases. Diffusion restric-
tion was detected in solid portions of the tumor in
89.6% of cases, while no diffusion restriction was ob-
served in the necrotic portion of the tumor. Signs of
bleeding were found in 44.4% of cases. In GBM cases
optic nerves, chiasma or tracts were infiltrated in 5.6%;
the affection of other cranial nerves was not found. Only
2 cases were exceptional. In one case, the lesion was
Fig. 2 a) FLAIR, axial scan b) DWI, ADC map, axial scan c) DWI, b=1000, axial scan d) SE T1 WI after intravenous gadolinium contrast administration,
axial scan e) SE T1 WI after intravenous gadolinium contrast administration, coronal scan f) FSE T2 WI with fat saturation, coronal scan
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localized infratentorially with nonhomogeneous en-
hancement (Fig. 7). In the second exceptional case, a
non-enhancing supratentorial lesion was present sus-
pected to be low-grade glioma; however, histology con-
firmed the diagnosis of GBM (WHO Grade IV).
Several significant differences between both brain infil-
trative tumors were found (see Table 3). Notably, no
homogenous enhancement was found in GBM, in con-
trast to homogeneous enhancement detected in 64.8% of
PCNSL lesions (p < 0.001). Enhancement in GBM was
nonhomogeneous in 98.1% of cases (no enhancement in
1 case) and necrosis was present in 88.9% of cases. Con-
versely, necrosis was present only in 5.6% of PCNSL
cases and nonhomogeneous enhancement in 14.8% of
PCNSL cases (both p < 0.001). Diffuse infiltrative type of
brain involvement was observed only in PCNSL (24.1%
of cases). Additionally, optic pathways infiltration was
more frequent in PCNSL than in GBM (p < 0.001);
present in 42.6% of PCNSL cases and only in 5.6% of
GBM cases. Signs of bleeding were more common in
GBM (44.4%) than PCNSL (5.6%); p < 0.001. Both supra-
tentorial and infratentorial localization was present only
in PCNSL (27.7%). The basal ganglia were involved more
often in PCNSL (55.6%) than in GBM (18.5%); p < 0.001.
Finally, cerebral cortex was affected significantly often in
GBM (83.3%) than in PCNSL (51.9%); mostly by both
enhancing and non-enhancing infiltration. In the Table 4
you can find combinations of several MRI findings and
their occurrence in both groups. According those find-
ings we constructed the diagram of the decision tree
analysis (Fig. 8). According to Tables 3 and 4, major cri-
teria in decision making process between PCNSL and
GBM are the type of enhancement and presence or ab-
sence of necrosis. As minor criteria we considered basal
ganglia and optic pathways affections, signs of bleeding,
both supratentorial and infratentorial localization and
diffuse infiltrative type of lesion.
Discussion
In the present study, we compared morphological MRI
characteristics in PCNSL and GBM at time of initial
MRI. At initial evaluation, PCNSL lesions were pre-
sented as multiple infiltrative lesions, which enhanced
homogenously or as diffuse infiltrative affection of the
brain. GBM typically manifested as a supratentorial soli-
tary infiltrative tumor nearly in all cases nonhomoge-
neous enhancement was present with evident necrosis.
Both GBM and PCNSL lesions reached the surface of
the brain in most cases; meningeal and ependymal infil-
tration was not uncommon.
We detected several significant differences between
PCNSL and GBM lesions. The most striking difference
was in enhancement patterns; while homogeneous en-
hancement was not detected in GBM, most PCNSL le-
sions (64.8%) enhanced homogeneously. Additionally,
necrosis was observed in most GBM lesions (88.9%) but
was rare in PCNSL (5.6%). Optic pathways infiltration
was common in PCNSL and rare in GBM. Other cranial
nerves infiltrations were not frequent and were found
only in PCNSL (5.6%). Signs of bleeding were rare in
PCNSL and common in GBM. The basal ganglia in-
volvement occurred more frequently in PCNSL than in
GBM. Diffuse infiltrative type of brain involvement was
observed only in PCNSL (24.1%) and also only PCNSL
was localized both supratentorial and infratentorial
(27.7%). Finally, cerebral cortex was affected significantly
often in GBM (83.3%) than in PCNSL (51.9%); mostly by
both enhancing and non-enhancing tumorous infiltra-
tion. Solitary non-enhancing tumorous affection of
cerebral cortex in both diagnoses was uncommon.
Our MRI findings in GBM are in agreement with
those reported previously [17]. However, our findings in
PCNSL are only partially consistent with those reported
by Haldorsen et al. [18]. In the present study, immuno-
competent PCNSL patients presented with multiple le-
sions in 51.9% of cases, and with involvement of the
basal ganglia in 55.6% cases. In contrast, Haldorsen et al.
reported multiple lesions in only 35% of PCNSL cases,
with basal ganglia involvement in 32% of cases [18].
However, they also reported disseminating lesions in 7%
of cases [18]. In our study we used category diffused in-
filtrative affection and probably this category is equal to
Haldorsen´s disseminating lesions. We found diffuse in-
filtrative brain affection by PCNSL in 24.1% of cases.
Fig. 3 PCNSL. The involvement of the right optic chiasma
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They also did not report the presence or absence of cra-
nial nerve infiltration [18]. In our study, optic pathways
involvement was present in 42.6% of PCNLS cases, other
cranial nerves were affected in 5.6%. In one case, solitary
auditory nerve involvement was present without other
lesions. Several case reports have been published de-
scribing solitary involvement of the auditory nerves in
PCNSL manifesting by sudden hearing lost [19, 20]. Cra-
nial nerve and leptomeningeal involvement is considered
very common in secondary CNS lymphoma [21]; how-
ever, systematic lymphoma was excluded in our patients.
One difficulty in comparing our results to those reported
previously is that many studies are limited by small sam-
ple sizes [22, 23]. Therefore, we consider the study of
Haldorsen et al. as the most reliable for comparison with
our results [18]. Their population-based study evaluated
CT/MRI features in 75 AIDS-negative patients in
Norway between the years 1989-2003 [18]. However,
only 52 patients underwent MRI, the rest of patients
were examined only by CT, and considering the fact that
sensitivity of CT is significantly lower than MRI, some
lesions may have been missed [18]. Haldorsen et al. also
included patients with immunosuppression therapy (5%)
and also 6 patients, in whom only imaging after cortico-
steroid therapy was available. Differences between our
results are partly explainable by designs of patient selec-
tion. We could also a little bit hypothesize about chan-
ging imaging findings in the time.
Fig. 4 a PCNSL. Solitary involvement of the left auditory nerve. b PCNSL. Three months follow-up with progression of PCNSL and cerebellar affection
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A number of studies have explored advanced MRI
techniques such as DWI, perfusion imaging and MR
spectroscopy [15, 24]. As PCNSL is highly cellular, diffu-
sion is often restricted. We detected diffusion restriction
in 97% of our PCNSL cases. Accordingly, Toh et al. re-
ported significantly lower fractional anisotropy (FA) and
apparent diffusion coefficient (ADC) in PCNSL com-
pared to GBM [25]. Although diffusion restriction is also
often present in the solid portion of GBM tumors
(89.6% in our GBM group), it is important to note than
there is generally free diffusion in the necrotic or cystic
portions of GBM tumors. The importance of revasculari-
zation through angiogenesis for tumor growth has led to
a growing interest in novel imaging techniques such as
the assessment of tumor vascularity. MR perfusion im-
aging can visualize nutritive delivery of arterial blood to
Fig. 5 a) FSE T2 WI, axial scan b) SE T1 WI after intravenous gadolinium contrast administration, axial scan c) DWI, b=1000, axial scan d) DWI, ADC
map, axial scan
Fig. 6 GBM. GBM with ependymal involvement
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the capillary bed in tumors. According to published data,
PCNSL demonstrates lower relative mean cerebral blood
volume than GBM; likely due to massive leakage of con-
trast media into the interstitial space [15]. In the MR
spectroscopy study by Yamasaki et al., a large lipid peak
on 1H-MR spectroscopy images in PCNSL and small or
absent lipid peak in GBM without necrosis was found
[24]. MR perfusion and spectroscopic data were available
only in few cases in the present study, thus we did not
have sufficient data for comparison.
PCNSL and GBM are serious malignant brain tumors
with different therapeutic management. Histological
verification of PCNSL before oncological treatment is
mandatory. Open surgery in PCNSL is not necessary;
the diagnostic method of choice is stereotactic biopsy,
which is not without complication [26]. We believe that
the MRI morphological differences between PCNSL and
GBM reported in the present study may be useful in
daily radiological practice and may help to differentiate
between both malignant entities.
The present study has several limitations. Due to its
retrospective nature, some MRI examinations were of
lower quality and acquired on different whole-body sys-
tems. As stated above, we did not have sufficient data
for reviewing advanced MRI techniques such as MR
spectroscopy or perfusion, also we do not have sufficient
data for FA evaluation and not all patients underwent
DWI and for measurement of ADC value. In limitations
of the study we must mention the fact of relative inci-
dence of both conditions. PCNSL occur less frequently
than GBM. This fact makes the diagnosis more complex
as no simple morphological feature is able to discrimin-
ate between these conditions. We tried to extract combi-
nations of relevant features and provide radiological
clues for further work-up.
Conclusions
Routine morphological MRI is capable of differentiating
between GBM and PCNSL lesions in many cases at time
of initial presentation. PCNSL often presented as
Fig. 7 GBM. Cerebellar GBM in a young woman
Table 4 Combinations of several MRI findings and their occurrence in PCNSL and GBM at the time of their initial evaluation





3 (23.1%) of 13 solitary cases
(5.6% of all PCNSL)
28 (77.8%) of 36 solitary cases





4 (30.8%) of 13 solitary cases
(7.4% of all PCNSL)
34 (94.4%) of 36 solitary cases




27 (96.4%) of 28 multiple cases
(50% of all PCNSL)
0 (0%) of 18 multiple cases
(0% of all GBM)
<0.001




0 (0%) of all GBM cases <0.001
•Multiple infiltrative
• Non-homogenous enhancement
1(3.6%) of 28 multiple cases
(1.9% of all PCNSL)
18 (100%) of 18 multiple cases
(33.3% of all GBM)
<0.001
Statisticaly significant results are in bold (p less than 0.05)
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multiple lesions that enhanced homogenously, often
with optic pathways infiltration and involvement of the
basal ganglia or as diffuse infiltrative type of brain in-
volvement. A solitary supratentorial lesion with nonho-
mogeneous enhancement and necrosis presence was
typical for GBM.
Abbreviations
ADC: apparent diffusion coefficient; CNS: central nervous system; DLBCL: diffuse
large B-cell lymphoma; DWI: diffusion-weighted images; FLAIR: T2-weighted
fluid-attenuated inversion recovery; FSE: fast spin echo; GBM: glioblastoma;
GE: gradient echo; MRI: magnetic resonance imaging; PCNSL: primary central
nervous system lymphoma; SWI: susceptibility-weighted images; T: tesla; T1
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Fig. 8 Decision tree analysis in considering PCNSL and GBM
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